Literature DB >> 3794396

Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.

H Masur, C Tuazon, V Gill, G Grimes, B Baird, A S Fauci, H C Lane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3794396     DOI： 10.1093/infdis/155.1.127

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  24 in total

1.  Opportunistic infections in HIV-infected patients.

Authors:  S D Shafran
Journal:  Can J Infect Dis       Date:  1992-03

2.  In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins.

Authors:  H Saito; H Tomioka; K Sato; M Emori; T Yamane; K Yamashita; K Hosoe; T Hidaka
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  Cloning and expression of the gene for the cross-reactive alpha antigen of Mycobacterium kansasii.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; K Terasaka; T Yamada
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 4.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 5.  The use of rifabutin in Europe for the treatment of mycobacterial infection in AIDS patients.

Authors:  B Dautzenberg
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 3.553

6.  Comparison of BACTEC 13A medium and Du Pont isolator for detection of mycobacteremia.

Authors:  F G Witebsky; J F Keiser; P S Conville; R Bryan; C H Park; R Walker; S H Siddiqi
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

7.  Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome.

Authors:  D M Yajko; J Kirihara; C Sanders; P Nassos; W K Hadley
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

8.  Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice.

Authors:  N Düzgüneş; V K Perumal; L Kesavalu; J A Goldstein; R J Debs; P R Gangadharam
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

9.  Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.

Authors:  F de Lalla; R Maserati; P Scarpellini; P Marone; R Nicolin; F Caccamo; R Rigoli
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

Review 10.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.